Propionyl-L-Carnitine in Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

December 31, 2009

Conditions
Ulcerative Colitis
Interventions
DRUG

Propionyl-L-Carnitine

PLC colon release tablet 1 g/die for 4 weeks

DRUG

Propionyl-L-Carnitine

PLC colon release tablet 2 g/die for 4 weeks

DRUG

Placebo

Placebo PLC colon release tablet 2 g/die for 4 weeks

Trial Locations (15)

20157

"Ospedale L. Sacco", Milan

47100

Hospital Morgagni - Pierantoni, Forlì

50009

Kaunas Medical University Clinic, Kaunas

80131

University Federico II, Naples

107014

"Federal State Institution 7-th Central Military Clinical Aviation Hospital of Ministry of Defence of Russia", Moscow

123154

"Federal State Institution State Scientific Centre of Coloproctology of Rosmedtechnologij", Moscow

193163

"State Institution Regional Military Clinical Hospital № 442 named after Z.P. Solovyov of Ministry of Defence of Russia", Saint Petersburg

194291

"Federal State Healthcare Institution Clinical Hospital № 122 named after L.G. Sokolov of Federal Medical and Biological Agency", Saint Petersburg

196247

"St-Petersburg State Healthcare Institution Municipal Hospital № 26", Saint Petersburg

00135

Hospital S. Filippo Neri, Rome

00168

"Policlinico A. Gemelli", Rome

08661

Vilnius University Santariskiu Hospital, Vilnius

90-153

Klinika Przewodu Pokarmowego Szpital Kliniczny Nr 1, Lodz

50-326

Samodzielny Publiczny Szpital Kliniczny Nr 3 Katedra i Klinika Gastroenterologii AM, Wroclaw

51-149

Wojewódzki Szpital Specjalistyczny Klinika Gastroenterologii, Wroclaw

All Listed Sponsors
lead

sigma-tau i.f.r. S.p.A.

INDUSTRY

NCT01026857 - Propionyl-L-Carnitine in Ulcerative Colitis | Biotech Hunter | Biotech Hunter